IRIS UniCatt

Fasano, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.042
EU - Europa 3.567
AS - Asia 2.821
SA - Sud America 486
AF - Africa 84
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.023
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.945
SG - Singapore 1.308
DE - Germania 1.306
CN - Cina 750
SE - Svezia 513
BR - Brasile 374
UA - Ucraina 330
FR - Francia 327
IT - Italia 285
VN - Vietnam 226
GB - Regno Unito 210
IE - Irlanda 176
IN - India 117
FI - Finlandia 97
ID - Indonesia 93
RU - Federazione Russa 85
PL - Polonia 81
JP - Giappone 66
CA - Canada 47
TR - Turchia 45
AR - Argentina 42
HK - Hong Kong 32
NL - Olanda 32
BD - Bangladesh 30
MX - Messico 28
ES - Italia 26
ZA - Sudafrica 25
BE - Belgio 23
IQ - Iraq 21
CI - Costa d'Avorio 19
EC - Ecuador 18
AT - Austria 16
AU - Australia 16
SA - Arabia Saudita 16
IR - Iran 14
PK - Pakistan 14
MA - Marocco 12
PY - Paraguay 12
CO - Colombia 11
VE - Venezuela 11
BG - Bulgaria 10
LT - Lituania 10
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
GR - Grecia 8
IL - Israele 8
KE - Kenya 7
NP - Nepal 7
PH - Filippine 7
TN - Tunisia 7
BO - Bolivia 6
JO - Giordania 6
KR - Corea 6
KZ - Kazakistan 6
UZ - Uzbekistan 6
CL - Cile 5
DK - Danimarca 5
JM - Giamaica 5
RO - Romania 5
CH - Svizzera 4
DO - Repubblica Dominicana 4
EU - Europa 4
PA - Panama 4
PS - Palestinian Territory 4
SN - Senegal 4
UY - Uruguay 4
BY - Bielorussia 3
DZ - Algeria 3
EG - Egitto 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
MY - Malesia 3
NZ - Nuova Zelanda 3
AL - Albania 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GY - Guiana 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PT - Portogallo 2
TW - Taiwan 2
AM - Armenia 1
BH - Bahrain 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
QA - Qatar 1
Totale 11.017
Salva come PNG Salva come JPEG
Città #
Singapore 717
Chandler 573
Ashburn 450
San Jose 327
Dublin 172
Jacksonville 167
Beijing 140
San Mateo 137
New York 122
Nanjing 94
Wilmington 90
Jakarta 84
Lauterbourg 80
Los Angeles 80
Ho Chi Minh City 79
Ann Arbor 78
Dallas 77
Nürnberg 73
Hanoi 70
Warsaw 69
Dearborn 66
Boston 65
Woodbridge 63
Houston 62
Lawrence 56
Seattle 56
Tokyo 49
Munich 47
Fairfield 46
Frankfurt am Main 44
Lancaster 43
Hefei 42
Marseille 42
Milan 36
Nanchang 36
São Paulo 36
Redwood City 34
Cattolica 33
Moscow 32
Santa Clara 29
The Dalles 28
Buffalo 27
Redmond 27
Rome 27
Hong Kong 26
University Park 26
London 25
Shenyang 24
Norwalk 23
Princeton 23
Shanghai 23
Bremen 22
Council Bluffs 22
Izmir 22
Mountain View 22
Jiaxing 21
Chicago 20
Abidjan 19
Atlanta 19
Brussels 19
Hangzhou 19
Leawood 19
Changsha 17
Hebei 17
Orem 17
Boardman 16
Brooklyn 16
Montreal 16
Chennai 15
Stockholm 15
Fremont 13
Lappeenranta 13
Phoenix 13
Pune 13
Tianjin 13
Cambridge 12
Helsinki 12
Kent 12
Paris 12
Simi Valley 12
Toronto 12
Augusta 11
Guangzhou 11
Johannesburg 11
Kunming 11
Rio de Janeiro 11
Vienna 11
Zhengzhou 11
Brasília 10
Denver 10
Düsseldorf 10
Ankara 9
Da Nang 9
Poitiers 9
Amsterdam 8
Baku 8
Belo Horizonte 8
Curitiba 8
Mexico City 8
Turku 8
Totale 5.547
Salva come PNG Salva come JPEG
Nome #
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 268
The role of small intestinal bacterial overgrowth in Parkinson's disease 248
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 221
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 207
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 200
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 195
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 188
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis 187
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 185
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 183
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 182
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 174
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 173
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 171
Prevalence of small intestinal bacterial overgrowth in Parkinson's disease 169
Reliability of Clinical Diagnosis of Dystonia 165
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 162
Movement disorders in multiple sclerosis: Causal or coincidental association? 161
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 160
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 158
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 157
New olfactometric findings in Parkinson's disease 157
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 154
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 153
Dystonia gravidarum: a new case with a long follow-up 153
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 151
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 151
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 151
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 150
Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies 148
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 148
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 147
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 145
Punding and computer addiction in Parkinson's disease 142
Analysis of blink rate in patients with blepharospasm 141
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 139
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 139
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 138
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 138
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 138
Homotoxicology remedies versu desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial. 136
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 136
Management of status dystonicus: our experience and review of the literature 135
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al. 133
Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? 133
Safety and efficacy of rotigotine in individuals with Parkinson's disease aged 75 and older 130
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 130
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 130
Onset and progression of primary torsion dystonia in sporadic and familial cases 128
RARE AND SERIOS CARDIAC SIDE EFFECTS DURING ROPINIROLE TITRATION 126
The long-term effect of tetrabenazine in the management of Huntington disease 125
Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity 125
Tourettism in multiple sclerosis: a case report 124
MANAGEMENT OF PUNDING IN PARKINSON'S DISEASE: AN OPEN-LABEL PROSPECTIVE STUDY 123
Increased excretion of glycosaminoglycans in children with urinary incontinence compared to those with monosymptomatic nocturnal enuresis 122
Rare and serious cardiac side effects during ropinirole titration 121
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 120
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts 118
Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion 116
Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy 114
Humanitarian mission improves health conditions of schoolchildren in Ethiopia. the case of Adwa 114
Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study 112
Long-term consequences of optical coherence tomography findings during percutaneous coronary intervention: The Centro per la Lotta Contro L'infarto - Optimization of Percutaneous Coronary Intervention (CLI-OPCI) LATE study 112
Role of optical coherence tomography for distal left main stem angioplasty 108
Acute necrotizing encephalopathy: a relapsing case in a European adult 106
Randomized comparison of optical coherence tomography versus angiography to guide Bioresorbable vascular scaffold implantation: The OPTICO BVS study 106
Freezing of gait in Parkinson's disease: the paradoxical interplay between gait and cognition 105
Tetrabenazine 104
Pisa syndrome in Parkinson disease 103
Retrospective evaluation of the dose equivalence of Botox and Dysport in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story 96
Treatment of dystonia using trihexyphenidyl in costello syndrome 95
Long-term effects of pedunculopontine nucleus stimulation for pisa syndrome 94
Status dystonicus: predictors of outcome and progression patterns of underlying disease 93
Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life 91
Punding (PD) 90
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy 89
Movement disorders phenomenology in focal motor seizures 88
Implementation of the Current Dystonia Classification from 2013 to 2018 82
Psychogenic facial movement disorders: Clinical features and associated conditions 80
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease. 56
Totale 11.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.397
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 0 139 15
2021/2022787 63 79 20 45 44 26 21 119 35 69 114 152
2022/20231.562 183 211 119 226 115 197 80 144 190 21 57 19
2023/2024690 39 208 21 30 11 109 32 36 11 34 95 64
2024/20251.252 23 48 118 48 146 36 22 77 196 110 224 204
2025/20263.452 538 107 241 431 635 177 625 193 201 270 34 0
Totale 11.146